Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | KRT | RSKD |
|---|---|---|
| Price | $53.38 | $8.05 |
| Change today | ▼ 0.58% | ▲ 3.34% |
| Market cap | $1.06B | $1.06B |
| Return, 3 months | +58.4% | +53.0% |
| Return, year to date | +147.1% | +62.0% |
| Return, 1 year | +145.2% | +72.7% |
| P/E (TTM) | 21.4 | -73.2 |
| P/B | 6.4 | 5.1 |
| P/E percentile vs own 5y | 89th | 0th |
| Dividend yield | 3.37% | – |
| Revenue growth (YoY, latest qtr) | +9.9% | +21.8% |
| Net profit growth (YoY) | +168.3% | +21.7% |
| Gross margin | 40.7% | 51.3% |
| Operating margin | 12.8% | -4.7% |
| Net margin | 10.2% | -4.2% |
| Return on equity | 30.7% | -5.7% |
| Analyst target vs. price | -12.9% | -6.1% |
| Analyst buy share | 67% | 60% |
| RSI (14) | 63 | 73 |
| 30-day volatility | 27.8% | 58.7% |
| Max drawdown, 1 year | -17.4% | -25.4% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
